ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C / Kucherenko, A., Pampukha, V., Bobrova, I., Moroz, L., Livshits, L. (2015)
web address of the page http://jnas.nbuv.gov.ua/article/UJRN-0000683039
Cytology and genetics   А - 2019 /  Issue (2015, Т. 49, № 2)
Kucherenko A., Pampukha V., Bobrova I., Moroz L., Livshits L.
ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C
Cite:
Kucherenko, A., Pampukha, V., Bobrova, I., Moroz, L., Livshits, L. (2015). ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C. Cytology and genetics, 49 (2), 38-41. http://jnas.nbuv.gov.ua/article/UJRN-0000683039 | |
|
|
PDF